Evaluation status available after sign-in
About the journal
The International Journal of Biological Markers is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,800 USD. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 0393-6155 · 1724-6008
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,800 USD
- Articles in DOAJ
- 2009
- Declared review time
- 19 weeks
- Declared peer-review model
- other
- Official website
- https://journals.sagepub.com/home/JBM
Index listings
- DOAJ · 2024-10-28
- MEDLINE · 1986-01-01
- PUBMED · 2010-11-23
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 2,800 USD
- Declared review time (DOAJ)
- 19 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
2009
Most recent article
last month
Average review time (journal-declared via DOAJ)
19weeks
Works in OpenAlex
2350
Last recorded publication year
2025
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
57
i10-index
999
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-10-28
- Added to DOAJ
- 2024-10-28
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- Portico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 93%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- JBM
- Source type
- journal
- NLM unique ID (PubMed)
- 8712411
- Society affiliations
- Organisation for Oncology and Translational Research (OOTR)
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Breast Cancer Treatment Studies
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Breast Lesions and Carcinomas
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Inflammatory Biomarkers in Disease Prognosis
Show all subjects (75)
- Clinical Laboratory Practices and Quality Control
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
- Head and Neck Cancer Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Protease and Inhibitor Mechanisms
- Protease and Inhibitor Mechanisms
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Colorectal Cancer Treatments and Studies
- Genetic Associations and Epidemiology
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer-related molecular mechanisms research
- Prostate Cancer Treatment and Research
- Cancer Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Cancer Genomics and Diagnostics
- Protease and Inhibitor Mechanisms
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Hepatocellular Carcinoma Treatment and Prognosis
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Estrogen and related hormone effects
- Lung Cancer Treatments and Mutations
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Angiogenesis and VEGF in Cancer
- Inflammatory Biomarkers in Disease Prognosis
- Glycosylation and Glycoproteins Research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Radiopharmaceutical Chemistry and Applications
- Cancer Immunotherapy and Biomarkers
- Radiopharmaceutical Chemistry and Applications
- Gastric Cancer Management and Outcomes
- MicroRNA in disease regulation
Keywords (DOAJ)
- cancer biomarkers
- oncology
- solid tumors
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ